Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Feb 14;15:11795514221074663. doi: 10.1177/11795514221074663

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 1. — Guidelines recommending different oral AHAs as second-line therapy in T2DM.^3,5,11-25

AGI, alpha-glucosidase inhibitors; DPP-4i, dipeptidyl peptidase 4 inhibitor; SGLT-2i, sodium–glucose transport protein 2 inhibitor; SU, sulfonylurea; TZD, thiazolidinediones.

Guidelines: International: American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD), International (IDF), World Health Organization (WHO), American Association of Clinical Endocrinologists (AACE), National Institute for Clinical Excellence (NICE), International Society for Pediatric and Adolescent Diabetes (ISPAD); National: India, Nepal, Bangladesh, Pakistan, Sri Lanka, Canada, Colombia, Australia, Egypt, Nigeria, Uganda, Middle East and North Africa, China, Korea, Singapore, Austria, Belgium, Germany, Greece, Hungary, Israel, Italy, Netherlands, Poland, Portugal, and Romania.